Phase 1 Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Part 1 – Healthy participants:
- Men and women aged 18 to 55 who are in good general health and have no childbearing potential
Part 2 – Participants with atopic dermatitis (eczema):
- Men and women aged 18 or older who are not pregnant
- People who have had a diagnosis of atopic dermatitis for at least one year that has not been well controlled with creams or ointments
- People whose atopic dermatitis is rated as moderate to severe based on specific scoring measures assessed at both a screening visit and a baseline visit (confirm with trial site)
- People whose eczema covers at least 10% of their body surface area at both the screening and baseline visits
- People who report significant itch, based on daily ratings recorded in the week before the baseline visit
Who may not be able to join:
- People who have taken part in another clinical trial or used another experimental drug within the past 30 days (or longer, depending on the drug)
- People who are currently taking certain medications that are not permitted under the study rules (confirm with trial site)
- People who test positive for syphilis during the screening period
- People who show signs of active or latent tuberculosis (TB) based on a blood test during screening
- People with a history of immune system disorders, or who test positive for HIV
- People who have had a parasitic worm (helminth) infection in the past six months or currently have one
- People with a history of hepatitis B or hepatitis C, or who test positive for certain hepatitis B or hepatitis C markers during screening (some exceptions may apply for hepatitis B — confirm with trial site)
- Women who are able to become pregnant (Part 1 healthy participants only)
- People who smoke (Part 1 healthy participants only)
- People with atopic dermatitis who regularly use tanning beds (more than twice a week) or have had extended sun exposure within four weeks before the baseline visit
- People with atopic dermatitis who have an ongoing uncontrolled medical condition — such as uncontrolled diabetes, high blood pressure, severe obesity, thyroid, heart, lung, liver, kidney, nerve, or mental health conditions — that could put them at increased risk during the study, as judged by the treating doctor
- Women who are able to become pregnant (Part 2) unless a highly effective form of contraception is being used during the study and for a set period after the study treatment ends (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +81337978748
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part 1-Incidence of adverse events (AEs) and serious adverse events (SAEs); Part 2-Incidence of adverse events (AEs) and serious adverse events (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.